🇮🇳 India Stock Screener ← Switch market ⚡ HerAI

Medi Assist Healthcare Services Limited MEDIASSIST NSEPHARMA

Healthcare · Healthcare Plans · India
https://www.mediassist.in
Company Profile ↓
₹292.90
-47.33% 1Y
Mkt Cap₹2,188.02 Cr
P/E22.74
P/B2.62
Div. Yield0.67%
52W High₹567.61
52W Low₹292.90
Book Value₹115.06
EPS (TTM)₹12.88

Company Overview

Medi Assist Healthcare Services Limited, together with its subsidiaries, provides third-party administration services for health insurance claims in India and internationally. The company offers MAtrix, a claims administration platform; MAven, a fraud, waste, and abuse prevention platform; MAven IDP, an intelligent document processing platform; MAven Insights, an analytics and decision intelligence platform; MAven Global, a global benefits administration platform; and Network-as-a-Service platform, which provides access to a healthcare provider network. It also provides business support, health management, consultancy, contact center support, and other allied services related to the healthcare and health insurance sector. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 21.7% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 22.7, below the sector median of 36.4.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.06.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹904.77 Cr (+25.1% YoY); net profit ₹87.89 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +24.1%, earnings +17.4%.
  • 5-Year Trend Long-term compounding — revenue CAGR 21.7%, profit CAGR 5.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:21.67%
1 Year:24.10%

Compounded Profit Growth

5 Years:5.87%
1 Year:17.40%

Stock Price Performance

1 Year:-47.33%
6 Months:-14.04%
3 Months:-12.87%
1 Month:-12.98%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 0% of range
₹292.90 ₹567.61
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)35.56 · Neutral
Price Performance
1M-12.98%
3M-12.87%
6M-14.04%
1Y-47.33%
Valuation vs Sector

P/E of 22.74 is below the sector median of 36.43 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 21.7% over 5 years.
  • Generates positive free cash flow.

CONS

  • Trading 48.4% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
22.74
Industry PE
36.43
Forward P/E
16.18
PEG Ratio
-
Book Value
₹115.06
Price to Book
2.62
P/S
2.37
EV/EBITDA
11.13
Dividend Yield
0.67%

Growth (CAGR)

Revenue 5Y
21.67%
Profit 5Y
5.87%
Revenue (YoY)
24.10%
Earnings (YoY)
17.40%

Profitability & Returns

ROCE
10.89%
ROE
10.48%
ROA
6.40%
Profit Margin
9.80%
Op Margin
11.06%
Gross Margin
56.09%
EPS (Latest Qtr)
₹7.33
EPS (TTM)
₹12.88

Balance Sheet & Liquidity

Debt/Equity
0.06
Quick Ratio
1.20
Current Ratio
1.34
Debt
₹54.40 Cr
Total Assets
₹1,372.46 Cr
Current Assets
₹585.18 Cr
Working Capital
₹147.54 Cr

Ownership

Promoter Holding
13.62%
Chg in Prom Hold
0.88%
FII / Inst Holding
63.08%
Chg in FII Hold
0.42%

Financial Snapshot

Enterprise Value
₹2,188.02 Cr
Total Revenue (TTM)
₹950.73 Cr
EBITDA
₹185.73 Cr
Free Cash Flow
₹62.15 Cr
Operating Cash Flow
₹118.07 Cr
Shares Outstanding
₹7.47 Cr
Gross Margin
56.09%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 MEDIASSIST Medi Assist Healthcare Services Limited NSEPHARMA 292.90 22.74 ₹2,188.02 Cr 0.67% 10.89% 10.48% 21.67% 5.87%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,745.10 34.62 ₹4.19 L Cr 0.91% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 9,190.00 83.58 ₹2.44 L Cr 0.32% 18.96% 15.32% 10.98% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,553.80 72.74 ₹1.73 L Cr 0.81% 9.05% 25.79% 13.27% 20.22%
5 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,117.30 24.90 ₹1.11 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
6 LENSKART Lenskart Solutions Limited NIFTY_MIDNSEPHARMA 631.35 164.41 ₹1.09 L Cr 0.00% 7.21% 5.65% 35.38% 66.99%
7 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 7,600.00 52.32 ₹1.09 L Cr 0.25% 19.20% 20.48% 14.85% 33.34%
8 LAURUSLABS Laurus Labs Limited NIFTY_MIDNSEPHARMA 2,012.50 99.48 ₹1.09 L Cr 0.12% 19.53% 16.77% 3.77% 4.00%
9 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,314.00 31.51 ₹1.06 L Cr 0.99% 14.86% 11.27% 7.23% 11.45%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 125.00 Cr136.00 Cr141.00 Cr166.00 Cr167.00 Cr168.00 Cr181.00 Cr-188.87 Cr190.56 Cr232.54 Cr239.68 Cr241.99 Cr
Cost of Revenue --------78.92 Cr79.86 Cr105.45 Cr103.37 Cr105.38 Cr
Gross Profit --------109.95 Cr110.69 Cr127.09 Cr136.30 Cr136.60 Cr
Operating Expenses 95.00 Cr105.00 Cr118.00 Cr132.00 Cr130.00 Cr132.00 Cr142.00 Cr-83.31 Cr82.79 Cr108.31 Cr112.82 Cr109.29 Cr
Operating Income 25.00 Cr23.00 Cr14.00 Cr23.00 Cr25.00 Cr21.00 Cr24.00 Cr-26.64 Cr27.90 Cr18.79 Cr23.49 Cr27.31 Cr
EBITDA 31.00 Cr31.00 Cr22.00 Cr34.00 Cr37.00 Cr35.00 Cr38.00 Cr-48.51 Cr49.40 Cr41.99 Cr37.99 Cr49.51 Cr
Interest Expense 1.00 Cr1.00 Cr1.00 Cr1.00 Cr1.00 Cr2.00 Cr2.00 Cr-4.36 Cr4.78 Cr7.59 Cr8.39 Cr65.00 L
Pretax Income 30.00 Cr23.00 Cr18.00 Cr26.00 Cr28.00 Cr25.00 Cr30.00 Cr-30.05 Cr30.51 Cr13.47 Cr8.47 Cr27.90 Cr
Tax Provision 8.40 Cr7.36 Cr54.00 L4.42 Cr2.52 Cr6.00 Cr8.70 Cr-8.41 Cr7.88 Cr5.40 Cr4.33 Cr-26.57 Cr
Net Income 22.00 Cr16.00 Cr18.00 Cr21.00 Cr26.00 Cr19.00 Cr21.00 Cr-21.49 Cr22.40 Cr7.95 Cr4.17 Cr53.44 Cr
Diluted EPS 3.132.302.582.983.582.682.99-3.043.161.120.517.33

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 277.00 Cr319.00 Cr323.00 Cr-502.38 Cr633.29 Cr723.32 Cr904.77 Cr
Cost of Revenue ----61.10 Cr70.00 Cr305.86 Cr394.07 Cr
Gross Profit ----441.27 Cr563.29 Cr417.46 Cr510.69 Cr
Operating Expenses 194.00 Cr237.00 Cr247.00 Cr-346.65 Cr460.13 Cr319.13 Cr413.21 Cr
Operating Income 59.00 Cr55.00 Cr44.00 Cr-94.62 Cr103.16 Cr98.33 Cr97.48 Cr
EBITDA 82.00 Cr82.00 Cr76.00 Cr-133.30 Cr130.58 Cr177.87 Cr178.89 Cr
Interest Expense 4.00 Cr4.00 Cr6.00 Cr-2.92 Cr3.12 Cr10.30 Cr21.41 Cr
Pretax Income 41.00 Cr59.00 Cr49.00 Cr-103.61 Cr84.39 Cr111.79 Cr80.35 Cr
Tax Provision 15.17 Cr24.19 Cr23.03 Cr-28.30 Cr13.09 Cr20.19 Cr-8.96 Cr
Net Income 26.00 Cr35.00 Cr26.00 Cr-74.06 Cr66.94 Cr90.88 Cr87.89 Cr
Diluted EPS 7,254.859,576.187,064.52-10.769.5312.8512.14

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 518.00 Cr558.00 Cr545.00 Cr-705.72 Cr850.58 Cr1,158.23 Cr1,372.46 Cr
Current Assets ----442.13 Cr477.68 Cr751.38 Cr585.18 Cr
Cash & Equivalents ----53.94 Cr50.93 Cr83.01 Cr54.63 Cr
Inventory --------
Receivables ----127.16 Cr178.62 Cr221.36 Cr286.68 Cr
Total Liabilities ----322.04 Cr369.25 Cr606.07 Cr520.06 Cr
Current Liabilities ----278.54 Cr319.46 Cr504.26 Cr437.64 Cr
Long Term Debt -----013.32 Cr0
Total Debt 98.00 Cr115.00 Cr35.00 Cr-30.68 Cr26.33 Cr203.69 Cr54.40 Cr
Total Equity 218.04 Cr212.04 Cr290.04 Cr-376.61 Cr471.74 Cr541.47 Cr838.90 Cr
Shares Outstanding ----6.89 Cr7.02 Cr7.05 Cr7.46 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 35.00 Cr19.00 Cr139.00 Cr-81.08 Cr66.38 Cr138.09 Cr118.07 Cr
Investing Cash Flow -21.00 Cr-22.00 Cr-61.00 Cr--10.49 Cr-54.86 Cr-218.24 Cr-159.63 Cr
Financing Cash Flow -10.00 Cr-12.00 Cr-10.00 Cr--31.52 Cr-14.76 Cr112.07 Cr11.85 Cr
Capital Expenditure -21.00 Cr-21.00 Cr-13.00 Cr--27.67 Cr-18.42 Cr-45.79 Cr-55.92 Cr
Free Cash Flow 14.00 Cr-2.00 Cr126.00 Cr-53.41 Cr47.96 Cr92.29 Cr62.15 Cr
Net Change in Cash 4.00 Cr-15.00 Cr69.00 Cr-39.07 Cr-3.24 Cr31.91 Cr-29.72 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ----87.8%88.9%57.7%56.4%
Operating Margin % 21.3%17.2%13.6%-18.8%16.3%13.6%10.8%
Net Margin % 9.4%11.0%8.0%-14.7%10.6%12.6%9.7%
ROE % 11.9%16.5%9.0%-19.7%14.2%16.8%10.5%
ROCE % ----22.1%19.4%15.0%10.4%

Shareholding Pattern

Insiders
13.62%
Institutions
63.08%
Public Float
73.03%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for MEDIASSIST

Google News Mon, 19 Oct 2026

Medi Assist Healthcare Services Dividend 2026: ₹2.00 & History - INDmoney

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPRl83Vk5WZkQ5UjBSaUM1TkJOeWtiVVpEdFFaYXRQMWtnazlxRHFHXzRCYVN3QjByZW1RTjFpTml6VkVTbFhxeUxwSUp4LW9TVEh3MUwtZGsyTFNBakFqLVNkMmpHWkxHR3VTc3ZWbGl4a1AzUnIxNjlWY20zMWttWXdZZ2ctOVZSdUFvOX…

Google News Fri, 26 Jun 2026

MEDIASSIST Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTFAzRFdEZjY1bDJ5dmdxbWRpOU9nd0xrUEQyU3EzaWwtUGo1MFEtcW1Cdy16UUJuY05uN2tlNFoxRlJ6MzBBN3phN092NE5yQjhfZ0h3TjhHTlVKVnJicFBsZDBYcE43dHJYVFpZdFIzMTl2ZUpTekVIR3ZBdFVPdw?oc=5" target="_blan…

Google News Wed, 07 Oct 2026

Medi Assist Healthcare Services (NSEI:MEDIASSIST) Stock Forecast & Analyst Predictions - Simply Wall Street

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQUTEtUnpwYm1JRG1WRkJ2NEYwVkpTdFQ4S3VYYTNNRVRNaURiR1Ayd29UWkhNbXp0SXV5UFZPT05NMTA1ZHZiQjRudEpkMWo3S2JZRU9JVjJ2UUNCbGNYMVFoUjZQT3pwNk11dmlOUlhteTRfd3F0YzRsVlhlMmRPZ1VsRTlxSFZ0bEhTbW…

Google News Mon, 10 Aug 2026

Medi Assist Q1 FY27 slides: margin recovery continues, tech revenue surges - Investing.com Nigeria

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPZGw4TW00TC1DV0ZlNW5QMmxCVDZuaTFGM2xRUzhFRWVGNllTdERJdTVjcnVvYktPRHdFUWctNTE3VlZGQ2dWRk5ZVjhVeEo0dXBzMjJybGZfR0QtM24xZlJEb2RIdEp2WlVyNzg0WnJLcGR1UnQ2Q3lySURoblVvX1dOTEY1UnhqRU5Odj…

Google News Sun, 11 Oct 2026

Medi Assist Healthcare Services’ Q4 PAT jumps 51%, operating revenue rises 23% - Upstox

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNZ0xXYzdrcDRKM3ZBNy04RWlsRHlRdjFGYXIyMVRtTjlRSzlWZUtldUxIUFYxWGh3UnJtSzh5cDh6d3dHQ2txeVJEZ3IwbmVTSkVKZjBaQkJET2RNb1ExekMwTlNRZVRVQ1Nkc0p6V2hsd3QybTN5NFp1SUk5RGVSRVgtNHgxcjlVbUNSTU…

Google News Wed, 23 Sep 2026

Five Stocks To Buy Today: RBL Bank, Medi Assist Healthcare, Milky Mist Dairy Food | Sept 23 - NDTV Profit

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPN1gwTVZDakZJNzF1bGl0Zm9HQ0dMbHBjbV9SOFlxX05vX2hFRW9RdEN4d0pPZ2x2V0VwX196U0J6LWFwZDNOM3JHTmJka0hzR1Y5WDk1cEE0eFNfYlAtaUJRcktEWjFWQmJ6cGpoWEUyRlVhb3htX1JjYlhWQXVpR25ab2xRVVpMajNONn…

MEDIASSIST — Frequently Asked Questions

What is the current share price of Medi Assist Healthcare Services Limited (MEDIASSIST)?

As of 2026-10-23 04:58 IST, Medi Assist Healthcare Services Limited (MEDIASSIST) trades at ₹292.90 on NSE. Its 52-week range is ₹292.90 to ₹567.61.

What is the market capitalisation of MEDIASSIST?

Medi Assist Healthcare Services Limited (MEDIASSIST) has a market capitalisation of ₹2,188.02 Cr on NSE.

What is the P/E ratio of MEDIASSIST?

MEDIASSIST trades at a trailing price-to-earnings (P/E) ratio of 22.74. The industry average P/E is 36.43. Its price-to-book (P/B) ratio is 2.62.

Does MEDIASSIST pay a dividend?

Medi Assist Healthcare Services Limited (MEDIASSIST) currently offers a dividend yield of 0.67%.

What is the return on equity (ROE) of MEDIASSIST?

MEDIASSIST has a return on equity (ROE) of 10.48%. Its return on capital employed (ROCE) is 10.89%.

Is MEDIASSIST a good stock to buy?

This page provides a data-driven analysis of Medi Assist Healthcare Services Limited (MEDIASSIST), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space